14 July 2020
Older adults shoulder a disproportionate burden of chronic diseases and consumption of prescription drugs. Nevertheless, older adults, especially those aged over 75 years, are chronically under-represented in clinical trials. In this two part series, Dr Kiri Granger explores the risks of under-presentation and outlines guidance for including older adults in clinical trials.
Read on for session two: key design considerations when including elderly patients in clinical trials, with a focus on cognitive assessment.
14 July 2020
Older adults are consistently under-represented in clinical trials, even though they take more prescription medications than any other group. In this two part series, Dr Kiri Granger will explore this under-presentation and outline practical considerations for including older adults in clinical trials.
Read on for session one: the importance of addressing the evidence-practice gap.
2 July 2020
People actively manage their fatigue through a range of medical and non-medical approaches, but many are not satisfied with existing treatments. In order to find out more from this highly motivated patient group, we conducted a study into their lived experiences.
23 June 2020
We caught up with Jana Thomas of Radboud University Medical Centre to find out more about the bidirectional relationship between poor sleep and Alzheimer’s disease.
17 June 2020
Fatigue is multifaceted, complicated and changeable. In order to delve deeper into the complexities of living with fatigue we asked patients with chronic health conditions to share their experiences. Read on to find out what we heard.
11 June 2020
Remote testing solutions for clinical trials and academic research are increasingly being adopted resulting in time and cost savings for clinical research studies and reduced participation burden for study patients. However, not every study is suitable for this medium. In this article we cover the scientific and operational factors for deciding whether to use remote cognitive testing in an upcoming trial.